Not unique to Pab. Nobody in Oz biotech are landing blockbuster deals (bodacious upfronts, bombastic milestones and heroic royalty rates) either. What's wrong with oz biotech may be the right question.
Having said that, not many have tie ups (albeit lazy n loose) with Amgen.
good for pab/sm6, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(7.14%) |
Mkt cap ! $13.37M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $264 | 42.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 6055648 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1726391 | 6 |
View Market Depth
| Last trade - 14.46pm 22/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |